vs
Side-by-side financial comparison of Ares Commercial Real Estate Corp (ACRE) and American Healthcare REIT, Inc. (AHR). Click either name above to swap in a different company.
American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $13.2M, roughly 42.7× Ares Commercial Real Estate Corp). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs -29.2%, a 31.2% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -24.5%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs -15.9%).
Ares Commercial Real Estate Corp is a specialty finance company focused on the commercial real estate sector. It offers a full suite of customized financing solutions including senior mortgage loans, subordinated debt and preferred equity, primarily serving middle-market commercial property owners and operators across the United States.
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
ACRE vs AHR — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $564.0M |
| Net Profit | $-3.9M | $10.8M |
| Gross Margin | — | 14.8% |
| Operating Margin | -29.2% | 19.8% |
| Net Margin | -29.2% | 1.9% |
| Revenue YoY | -24.5% | 13.5% |
| Net Profit YoY | 63.8% | 133.9% |
| EPS (diluted) | — | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $564.0M | ||
| Q3 25 | $14.1M | $532.1M | ||
| Q2 25 | $12.6M | $501.3M | ||
| Q1 25 | $14.9M | $497.2M | ||
| Q4 24 | $17.5M | $496.8M | ||
| Q3 24 | $16.7M | $476.8M | ||
| Q2 24 | $16.8M | $458.0M | ||
| Q1 24 | $18.7M | $452.1M |
| Q4 25 | $-3.9M | $10.8M | ||
| Q3 25 | $4.7M | $55.9M | ||
| Q2 25 | $-11.0M | $9.9M | ||
| Q1 25 | $9.3M | $-6.8M | ||
| Q4 24 | $-10.7M | $-31.8M | ||
| Q3 24 | $-5.9M | $-4.1M | ||
| Q2 24 | $-6.1M | $2.0M | ||
| Q1 24 | $-12.3M | $-3.9M |
| Q4 25 | — | 14.8% | ||
| Q3 25 | — | 14.6% | ||
| Q2 25 | — | 15.0% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 12.5% | ||
| Q2 24 | — | 12.1% | ||
| Q1 24 | — | 10.7% |
| Q4 25 | -29.2% | 19.8% | ||
| Q3 25 | 33.0% | 19.9% | ||
| Q2 25 | -87.8% | 20.6% | ||
| Q1 25 | 64.4% | 19.0% | ||
| Q4 24 | -61.0% | 20.0% | ||
| Q3 24 | -35.3% | 19.6% | ||
| Q2 24 | -36.5% | 19.4% | ||
| Q1 24 | -65.9% | 18.2% |
| Q4 25 | -29.2% | 1.9% | ||
| Q3 25 | 33.0% | 10.5% | ||
| Q2 25 | -87.8% | 2.0% | ||
| Q1 25 | 62.5% | -1.4% | ||
| Q4 24 | -60.9% | -6.4% | ||
| Q3 24 | -35.3% | -0.9% | ||
| Q2 24 | -36.5% | 0.4% | ||
| Q1 24 | -65.9% | -0.9% |
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.33 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.3M | $114.8M |
| Total DebtLower is stronger | $948.2M | — |
| Stockholders' EquityBook value | $509.6M | $3.3B |
| Total Assets | $1.6B | $5.4B |
| Debt / EquityLower = less leverage | 1.86× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.3M | $114.8M | ||
| Q3 25 | $84.9M | $147.4M | ||
| Q2 25 | $90.0M | $133.5M | ||
| Q1 25 | $125.5M | $86.1M | ||
| Q4 24 | $63.8M | $76.7M | ||
| Q3 24 | $68.9M | $67.8M | ||
| Q2 24 | $70.6M | $52.1M | ||
| Q1 24 | $99.5M | $77.0M |
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $509.6M | $3.3B | ||
| Q3 25 | $521.0M | $2.7B | ||
| Q2 25 | $523.7M | $2.4B | ||
| Q1 25 | $542.1M | $2.3B | ||
| Q4 24 | $540.1M | $2.3B | ||
| Q3 24 | $563.8M | $2.2B | ||
| Q2 24 | $582.3M | $1.9B | ||
| Q1 24 | $601.1M | $2.0B |
| Q4 25 | $1.6B | $5.4B | ||
| Q3 25 | $1.4B | $4.8B | ||
| Q2 25 | $1.4B | $4.5B | ||
| Q1 25 | $1.5B | $4.5B | ||
| Q4 24 | $1.8B | $4.5B | ||
| Q3 24 | $1.9B | $4.7B | ||
| Q2 24 | $2.1B | $4.6B | ||
| Q1 24 | $2.1B | $4.7B |
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $55.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 5.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.6M | $55.2M | ||
| Q3 25 | $3.8M | $107.2M | ||
| Q2 25 | $4.9M | $71.5M | ||
| Q1 25 | $8.0M | $60.6M | ||
| Q4 24 | $7.1M | $59.5M | ||
| Q3 24 | $8.4M | $63.1M | ||
| Q2 24 | $8.7M | $59.4M | ||
| Q1 24 | $11.4M | $-6.0M |
| Q4 25 | — | 5.12× | ||
| Q3 25 | 0.82× | 1.92× | ||
| Q2 25 | — | 7.21× | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 30.02× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACRE
Segment breakdown not available.
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
